Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Frank: Studies to Maximize Immunogenicity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2015-05-21 |
| Study Made Public: | 2015-12-03 |
Title
Linear Ab epitope mapping with mouse sera following immunization with alum-adjuvanted, stabilized 1086C and/or JRFL and a Complement Activator
Description
CAVD 496 is preclinical mouse study using specimens from a mouse study of Alum-adjuvanted, stabilized 1086C and/or JRFL and a Complement Activator.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.